Regenerative medicine is used to regenerate, replace and repair tissue or organ affected by the disease, injury, or natural aging process. This medicine reforms the function of tissue and cell and is used in several disorders such as orthopaedic disease, cardiovascular, and neurological disease. Stem cells are capable of differentiation and proliferation which is important in this field. In regenerative medicine, cell therapy is the most used application than gene therapy, tissue engineering, and biological & small molecules. For the preparation of this medicine biologically derived material is mostly used than others. There are very low chances of adverse reactions or infection from this medicine because it is made up of natural components of the body and tissue, and it provides pain relief to.
The untapped potential of nanotechnology and the emergence of stem cell technology are the main driving factors of the global regenerative medicine market. Moreover, the shortage of organ transplantation and the increasing prevalence of chronic diseases is the factor that is boosting the growth of the global market. Developed regions focus on technological advancement, and increasing focus on stem cell and growth in R & D is having a positive impact on the growth of the market. However, stringent government law and regulation, and high cost of treatment are the factors that may hamper the growth of the market. The market has the opportunity in doing R & D in stem cell technology and organ transplantation.
The exclusive COVID 19 impact analysis provides an analysis of micro and macro-economic factors on the regenerative medicine market. In addition, complete analysis of changes on healthcare expenditure, economic and international policies on supply and demand side. The report also studies the impact of the pandemic on global economies, international trade, business investments, GDP, and marketing strategies of key players present in the market. The COVID-19 epidemic will impact the regenerative medicine market in the preliminary phase of the forecast period. Due to nationwide lockdowns, denied wound care services, cancelled or postponed optional surgeries in COVID-19 medical care centres, the regenerative medicine market is anticipated to register a certain decline during the forecast period. However, during the latter half of the forecast period, the demand for regenerative medicine products is projected to rise considerably.
The study analyzed the global regenerative medicine market based on product type, material, application, and geography
The major type of products in the regenerative medicine market are cell therapy, gene therapy, tissue engineering, and small molecule & biologic. The cell therapy segment has lion’s share in the market, due to its efficiency to restore the lost function of tissues and organs. Moreover, small molecules & biologics segment grow with adequate rate, due to its potential to stimulate dormant or endogenous cells to regain their regenerative properties.
Synthetic material, biologically derived material, genetically engineered material, and pharmaceuticals are the materials which are mostly used in regenerative medicine market. The biologically derived material was the dominant segment and is estimated to maintain this trend during the forecast period. The demand for genetically engineered material has increased due to their unique properties such as the promotion of cellular interactions, increased proliferation, and differentiation of cells that facilitate self-assembly into directionally organized structures and control the manipulation of cellular behaviour.
The market finds applications in cardiovascular, oncology, dermatology, musculoskeletal, wound healing, ophthalmology, neurology, and others. The musculoskeletal disorders segment accounted for the largest market share. This can be attributed to the rising prevalence of orthopaedic diseases, growing geriatric population, increasing number of stem cell research projects, a growing number of clinical researches/trials, and the rich pipeline of stem cell products for the treatment of musculoskeletal disorders.
North America dominates the global regenerative medicine market, as the region is technologically advanced, has a developed pharmaceutical sector, and world class R & D centres that help the market to grow in this region. Moreover, funds provided by the government to R & D helps the market to grow. The market in the Asia Pacific grows with decent rate, owing to the rise in the pharmaceutical sector, pharmaceutical technology application, and increasing awareness about treatment. Presence of growing economies like India and China help is the major driving force behind the growth of the market in the region. The market in Latin America and Europe is expected to show steady growth rate, as the growth of the pharmaceutical sector in this region is steady.
The key competitor of the market includes Stryker Corporation, Organogenesis, Inc., Advanced Zimmer Biomet Holdings, Inc., Isto Biologics (Isto Biologics Medical Systems, Inc., Medtronic Plc., Athersys, Inc., U.S. Stem Cell, Inc. (Bioheart, Inc.), Integra Lifesciences Holdings Corporation, Acelity Holdings, Inc., CryoLife, Inc., and others.
The study analyses the global regenerative medicine market based on the type of product, material, therapeutic category, application, and geography. Types of regenerative medicines include cell therapy, gene therapy, tissue engineering, and small molecule & biologic in the marketplace. The cell therapy segment is likely to dominate the market over the forecast period. The market finds applications in cardiovascular, oncology, dermatology, musculoskeletal, wound healing, ophthalmology, neurology, and others. The musculoskeletal segment is likely to register the fastest growth in the upcoming years. Geographically, the study is comprised of the key countries of North America, Europe, Asia-Pacific, and the Rest of the World.
Why to Buy This Report: